Elliptic Laboratories AS (ELABS) — Capital Reinvestment Ratio
Elliptic Laboratories AS (ELABS) has a Capital Reinvestment Ratio of 4.85x as of December 2025, meaning it reinvests 5% of its operating cash flow (Nkr5.99 Million) in capital expenditures (Nkr29.08 Million). See ELABS equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Elliptic Laboratories AS Capital Reinvestment Ratio (2025–2025)
This chart tracks Elliptic Laboratories AS's Capital Reinvestment Ratio across 1 annual periods. Check ELABS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Elliptic Laboratories AS (2025–2025)
Year-by-year Capital Reinvestment Ratio for Elliptic Laboratories AS from 2025 to 2025. For live market cap and broader valuation context, see Elliptic Laboratories AS market capitalisation.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.85x | Nkr5.99 Million | Nkr29.08 Million | — |